GENERAL ATLANTIC L P's Q4 2025 13F: 1 new position, 4 exits
Form 13F-HR for the quarter ended Dec 31, 2025 · filed Feb 17, 2026 · 13 reported positions · accession 0000950142-26-000395
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| Exited | AKERO THERAPEUTICS (AKRO) | 8.2% | — | −8.2 pts | −5.73M sh | −100% |
| Reduced | ALIGNMENT HEALTHCARE (ALHC) | 12.7% | 9.1% | −3.7 pts | −11.12M sh | −46% |
| New | NURIX THERAPEUTICS (NRIX) | — | 3.2% | +3.2 pts | +4.9M sh | new |
| Reduced | CENTESSA PHARMACEUTICALS (CNTA) | 7.0% | 5.3% | −1.7 pts | −3.56M sh | −37% |
| Reduced | WEBULL (BULL) | 3.2% | 0.0% | −3.2 pts | −7.15M sh | −99% |
| Increased | CHIME (CHYM) | 11.6% | 18.6% | +7.0 pts | +2.05M sh | +11% |
| Reduced | XP, INC (XP) | 14.4% | 12.9% | −1.5 pts | −2.82M sh | −11% |
| Exited | ROYALTY PHARMA (RPRX) | 1.6% | — | −1.6 pts | −1.5M sh | −100% |
| Increased | REVOLUTION MEDICINES (RVMD) | 3.5% | 7.8% | +4.3 pts | +339K sh | +14% |
| Exited | ADAGENE (ADAG) | 0.2% | — | −0.2 pts | −3.78M sh | −100% |
| Exited | ALUMIS (ALMS) | 0.2% | — | −0.2 pts | −1.3M sh | −100% |
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
Top 10 positions — 99.0% of the equity book
Changes in the top 10 this quarter: NRIX entered · EWCZ entered · AKRO left · BULL left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | DLOCAL (DLO) | 20.0% | 23.0% | |
| 2 | CHIME (CHYM) | 11.6% | 18.6% | |
| 3 | XP, INC (XP) | 14.4% | 12.9% | |
| 4 | ALKAMI (ALKT) | 8.9% | 9.6% | |
| 5 | ALIGNMENT HEALTHCARE (ALHC) | 12.7% | 9.1% | |
| 6 | REVOLUTION MEDICINES (RVMD) | 3.5% | 7.8% | |
| 7 | PHARVARIS (PHVS) | 6.0% | 7.8% | |
| 8 | CENTESSA PHARMACEUTICALS (CNTA) | 7.0% | 5.3% | |
| 9 | NURIX THERAPEUTICS (NRIX) | 0.0% | 3.2% | Entered the top 10 |
| 10 | EUROPEAN WAX CENTER (EWCZ) | 1.6% | 1.6% | Entered the top 10 |
| — | AKERO THERAPEUTICS (AKRO) | 8.2% | 0.0% | Left the top 10 |
| — | WEBULL (BULL) | 3.2% | 0.0% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).